Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, ethinylestradiol/gestodene (Apleek®) cannot be endorsed for use within NHS Wales as a female hormonal contraception. |
||
|
||
Medicine details |
||
| Medicine name | ethinylestradiol/gestodene (Apleek®) | |
| Formulation | 60 micrograms/24 hours/13 micrograms/24 hours transdermal patch | |
| Reference number | 2019 | |
| Indication | Female hormonal contraception |
|
| Company | Bayer Healthcare Pharmaceuticals | |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 24/09/2014 | |